Prophase Labs Inc (PRPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 405 | 169 | 88 | 678 | 1,094 |
| Marketable Securities | N/A | 2 | N/A | N/A | 2 |
| Receivables | 3,284 | 20,086 | 20,204 | 20,058 | 31,638 |
| Inventories | 266 | 830 | 1,145 | 1,143 | 3,966 |
| Other current assets | 0 | 0 | 0 | 6,143 | 0 |
| TOTAL | $7,773 | $24,571 | $24,770 | $30,637 | $42,235 |
| Non-Current Assets | |||||
| PPE Net | 2,349 | 3,581 | 6,567 | 7,501 | 13,851 |
| Investments And Advances | 43,657 | 0 | 0 | 0 | 0 |
| Intangibles | 11,781 | 13,690 | 14,335 | 14,981 | 15,627 |
| Other Non-Current Assets | 142 | 199 | 4,439 | 10,081 | 20,095 |
| TOTAL | $57,929 | $17,470 | $25,341 | $32,563 | $49,573 |
| Total Assets | $65,702 | $42,041 | $50,111 | $63,200 | $91,808 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 954 | 2,425 | N/A | N/A | 2,670 |
| Accounts payable and accrued liabilities | 45,033 | 15,421 | 15,776 | 16,924 | 15,459 |
| Accrued Expenses | 151 | 226 | 194 | 182 | 160 |
| Other current liabilities | 4,904 | 2,035 | 1,663 | 2,115 | 1,620 |
| TOTAL | $55,287 | $25,626 | $24,052 | $32,134 | $28,698 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 436 | N/A | 1,779 | 2,925 |
| Deferred Revenues | 1,374 | 1,418 | 1,600 | 1,698 | 1,647 |
| Other Non-Current Liabilities | 2,000 | 2,000 | 7,529 | 18,559 | 17,246 |
| TOTAL | $3,554 | $4,979 | $10,941 | $23,713 | $24,984 |
| Total Liabilities | $58,841 | $30,605 | $34,993 | $55,847 | $53,682 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,179 | 41,541 | 41,541 | 41,879 | 23,874 |
| Common Shares | 29 | 29 | 29 | 23 | 18 |
| Retained earnings | -65,738 | -58,899 | -54,427 | -58,393 | -24,034 |
| Other shareholders' equity | 159 | 161 | -321 | -198 | -197 |
| TOTAL | $6,861 | $11,436 | $15,118 | $7,353 | $38,126 |
| Total Liabilities And Equity | $65,702 | $42,041 | $50,111 | $63,200 | $91,808 |